Cellebrite DI (CLBT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cellebrite DI (CLBT) has a cash flow conversion efficiency ratio of 0.170x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($82.23 Million) by net assets ($484.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cellebrite DI - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Cellebrite DI's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CLBT total debt and obligations for a breakdown of total debt and financial obligations.
Cellebrite DI Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cellebrite DI ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apeloa Pharmaceutical Co Ltd
SHE:000739
|
0.056x |
|
Ningbo Huaxiang Electronic Co Ltd
SHE:002048
|
0.039x |
|
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
|
N/A |
|
CCC Intelligent Solutions Holdings Inc.
NASDAQ:CCC
|
0.067x |
|
China World Trade Center Co Ltd
SHG:600007
|
0.059x |
|
Bank of Queensland Ltd
AU:BOQ
|
0.029x |
|
Shurgard Self Storage SA
BR:SHUR
|
0.019x |
|
Adecco Group AG Class N
SW:ADEN
|
0.141x |
Annual Cash Flow Conversion Efficiency for Cellebrite DI (2019–2025)
The table below shows the annual cash flow conversion efficiency of Cellebrite DI from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cellebrite DI worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $484.32 Million | $168.96 Million | 0.349x | -11.31% |
| 2024-12-31 | $336.02 Million | $132.17 Million | 0.393x | -86.81% |
| 2023-12-31 | $34.21 Million | $102.06 Million | 2.983x | +970.84% |
| 2022-12-31 | $73.86 Million | $20.58 Million | 0.279x | +156.68% |
| 2021-12-31 | $-73.35 Million | $36.05 Million | -0.492x | -147.15% |
| 2020-12-31 | $63.80 Million | $66.51 Million | 1.042x | +280.11% |
| 2019-12-31 | $58.83 Million | $16.13 Million | 0.274x | -- |
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more